Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
01 04 2023
Historique:
pmc-release: 01 04 2024
pubmed: 3 2 2023
medline: 17 3 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

The relationship between chronic obstructive pulmonary disease (COPD) and cardiovascular disease in people with HIV (PWH) is incompletely understood. We determined whether COPD is associated with risk of myocardial infarction (MI) among PWH, and if this differs for type 1 (T1MI) and type 2 (T2MI). We utilized data from five sites in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort, a multisite observational study. Our primary outcome was an adjudicated MI, classified as T1MI or T2MI. We defined COPD based on a validated algorithm requiring COPD diagnosis codes and at least 90-day continuous supply of inhalers. We conducted time-to-event analyses to first MI and used multivariable Cox proportional hazards models to measure associations between COPD and MI. Among 12 046 PWH, 945 had COPD. Overall, 309 PWH had an MI: 58% had T1MI ( N  = 178) and 42% T2MI ( N  = 131). In adjusted models, COPD was associated with a significantly increased risk of all MI [adjusted hazard ratio (aHR) 2.68 (95% confidence interval (CI) 1.99-3.60)] even after including self-reported smoking [aHR 2.40 (95% CI 1.76-3.26)]. COPD was also associated with significantly increased risk of T1MI and T2MI individually, and with sepsis and non-sepsis causes of T2MI. Associations were generally minimally changed adjusting for substance use. COPD is associated with a substantially increased risk for MI, including both T1MI and T2MI, among PWH. Given the association with both T1MI and T2MI, diverse mechanistic pathways are involved. Future strategies to decrease risk of T1MI and T2MI in PWH who have COPD are needed.

Identifiants

pubmed: 36728918
doi: 10.1097/QAD.0000000000003465
pii: 00002030-202304010-00005
pmc: PMC10041661
mid: NIHMS1858817
doi:

Types de publication

Observational Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

745-752

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL126536
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126538
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG057262
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA044112
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL137557
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036935
Pays : United States

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction . JAMA Intern Med 2013; 173:614–622.
Attia EF, Akgun KM, Wongtrakool C, Goetz MB, Rodriguez-Barradas MC, Rimland D, et al. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4 . Chest 2014; 146:1543–1553.
Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, Raffi F, Pialoux G, et al. HIV is associated with airway obstruction: a matched controlled study . AIDS 2018; 32:227–232.
Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era . Am J Respir Crit Care Med 2011; 183:388–395.
Cavailles A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD . Eur Respir Rev 2013; 22:454–475.
Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis . Lancet Respir Med 2015; 3:631–639.
Chandra D, Gupta A, Kinney GL, Fuhrman CR, Leader JK, Diaz AA, et al. The association between lung hyperinflation and coronary artery disease in smokers . Chest 2021; 160:858–871.
Goedemans L, Bax JJ, Delgado V. COPD and acute myocardial infarction . Eur Respir Rev 2020; 29:190139.
Galani J, Mulder H, Rockhold FW, Weissler EH, Baumgartner I, Berger JS, et al. Association of chronic obstructive pulmonary disease with morbidity and mortality in patients with peripheral artery disease: insights from the EUCLID trial . Int J Chron Obstruct Pulmon Dis 2021; 16:841–851.
Kunisaki KM, Dransfield MT, Anderson JA, Brook RD, Calverley PMA, Celli BR, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. a post hoc cohort analysis from the SUMMIT randomized clinical trial . Am J Respir Crit Care Med 2018; 198:51–57.
Corbacho B, Drummond M, Jones E, Espin J, Exposito Hernandez J, Borras JM. Regional versus centralized HTA: implications for the assessment of cancer drugs . Value Health 2015; 18:A342.
Perry TW, Pugh MJ, Waterer GW, Nakashima B, Orihuela CJ, Copeland LA, et al. Incidence of cardiovascular events after hospital admission for pneumonia . Am J Med 2011; 124:244–251.
Besutti G, Raggi P, Zona S, Scaglioni R, Santoro A, Orlando G, et al. Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients . HIV Med 2016; 17:178–187.
Chandra D, Gupta A, Fitzpatrick M, Haberlen SA, Neupane M, Leader JK, et al. Lung function, coronary artery disease, and mortality in HIV . Ann Am Thorac Soc 2019; 16:687–697.
Zifodya JS, Duncan MS, So-Armah KA, Attia EF, Akgun KM, Rodriguez-Barradas MC, et al. Community-acquired pneumonia and risk of cardiovascular events in people living with HIV . J Am Heart Assoc 2020; 9:e017645.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction . Eur Heart J 2012; 33:2551–2567.
Crane HM, Paramsothy P, Drozd DR, Nance RM, Delaney JA, Heckbert SR, et al. Types of myocardial infarction among human immunodeficiency virus-infected individuals in the United States . JAMA Cardiol 2017; 2:260–267.
Crothers K, Harding B, Whitney B, Delaney J, Nance R, Heckbert S, et al. COPD and the risk for myocardial infarction by type in people living with HIV. Conference on Retrovirus and Opportunistic Infections . Seattle, WA, USA: 2019.
Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems . Int J Epidemiol 2008; 37:948–955.
Fredericksen R, Crane P, Tufano J, Ralston J, Schmidt S, Brown T, et al. Integrating a web-based patient assessment into primary care for HIV-infected adults . J AIDS HIV Res 2012; 4:47–55.
Lawrence ST, Willig JH, Crane HM, Ye J, Aban I, Lober W, et al. Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting . Clin Infect Dis 2010; 50:1165–1173.
Crane HM, Lober W, Webster E, Harrington RD, Crane PK, Davis TE, et al. Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients . Curr HIV Res 2007; 5:109–118.
Nance RM, Crane HM, Ritchings C, Rosenblatt L, Budoff M, Heckbert SR, et al. Differentiation of type 1 and type 2 myocardial infarctions among HIV-infected patients requires adjudication due to overlap in risk factors . AIDS Res Hum Retroviruses 2018; 34:916–921.
Crane HM, Heckbert SR, Drozd DR, Budoff MJ, Delaney JA, Rodriguez C, et al. Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts . Am J Epidemiol 2014; 179:996–1005.
Crothers K, Rodriguez CV, Nance RM, Akgun K, Shahrir S, Kim J, et al. Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons . Pharmacoepidemiol Drug Saf 2019; 28:140–147.
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race . N Engl J Med 2021; 385:1737–1749.
Crane HM, Kadane JB, Crane PK, Kitahata MM. Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients . Curr HIV Res 2006; 4:97–106.
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test . Arch Intern Med 1998; 158:1789–1795.
WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility . Addiction 2002; 97 :1183–1194.
Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly NP, et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography . Circulation 2017; 135:116–127.
Raphael CE, Roger VL, Sandoval Y, Singh M, Bell M, Lerman A, et al. Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort . Circulation 2020; 141:454–463.
Attia EF, McGinnis KA, Feemster LC, Akgun KM, Butt AA, Graber CJ, et al. Association of COPD with risk for pulmonary infections requiring hospitalization in HIV-infected veterans . J Acquir Immune Defic Syndr 2015; 70:280–288.
Zifodya JS, Triplette M, Shahrir S, Attia EF, Akgun KM, Soo Hoo GW, et al. A cross-sectional analysis of diagnosis and management of chronic obstructive pulmonary disease in people living with HIV: opportunities for improvement . Medicine (Baltimore) 2021; 100:e27124.
Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, et al. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS) . BMC Med 2019; 17:149.

Auteurs

Kristina Crothers (K)

Veterans Affairs Puget Sound Healthcare System.

Robin M Nance (RM)

Department of Medicine.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Bridget M Whitney (BM)

Department of Medicine.

Barbara N Harding (BN)

Barcelona Institute of Global Health (ISGlobal) and Universitat Pompeu Fabra (UPF), Barcelona.
CIBER Epidemiolog ia y Salud Publica (CIBERESP), Madrid, Spain.

Susan R Heckbert (SR)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Matthew J Budoff (MJ)

Lundquist Institute at Harbor-University of California, Los Angeles (UCLA), Torrance.

William C Mathews (WC)

Department of Medicine, University of California San Diego, California.

Laura Bamford (L)

Department of Medicine, University of California San Diego, California.

Edward R Cachay (ER)

Department of Medicine, University of California San Diego, California.

Joseph J Eron (JJ)

University of North Carolina, Chapel Hill, North Carolina.

Sonia Napravnik (S)

University of North Carolina, Chapel Hill, North Carolina.

Richard D Moore (RD)

Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Jeanne C Keruly (JC)

Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Amanda Willig (A)

Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Greer Burkholder (G)

Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Matthew J Feinstein (MJ)

Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Michael S Saag (MS)

Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Mari M Kitahata (MM)

Department of Medicine.

Heidi M Crane (HM)

Department of Medicine.

Joseph A C Delaney (JAC)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.
College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH